Visibility Score
27/100
AI Mentions
18
AI Search Volume
219
As of June 25, 2026, Insulet (insulet.com) has an AI visibility score of 27 out of 100, based on 18 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 219 AI search volume. Compared to peers in the life sciences sector, Insulet ranks #7 of 7 in AI mention share of voice.
Insulet is a US-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Insulet appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Insulet has 18 total AI mentions across 1 tracked platforms, generating 219 in AI search volume.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Insulet
When AI assistants answer questions involving Insulet, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Insulet ranks #7 out of 7 competitors in AI mention share of voice, capturing 0% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Mindray, Masimo, Embecta.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| insulet.com (You) | 18 | 219 |
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (Mindray) | 985 | 505.0K |
| masimo.com (Masimo) | 430 | 94.2K |
| embecta.com (Embecta) | 127 | 25.6K |
| tandemdiabetes.com (Tandem Diabetes Care) | 85 | 1.5K |
| nihonkohden.com (Nihon Kohden) | 60 | 6.9K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.